{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T13:24:35Z","timestamp":1794489875550,"version":"4.9.1"},"reference-count":104,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,2,28]],"date-time":"2023-02-28T00:00:00Z","timestamp":1677542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,28]],"date-time":"2023-02-28T00:00:00Z","timestamp":1677542400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    The mechanisms triggering metastasis in pheochromocytoma\/paraganglioma are unknown, hindering therapeutic options for patients with metastatic tumors (mPPGL). Herein we show by genomic profiling of a large cohort of mPPGLs that high mutational load, microsatellite instability and somatic copy-number alteration burden are associated with\n                    <jats:italic>ATRX<\/jats:italic>\n                    \/\n                    <jats:italic>TERT<\/jats:italic>\n                    alterations and are suitable prognostic markers. Transcriptomic analysis defines the signaling networks involved in the acquisition of metastatic competence and establishes a gene signature related to mPPGLs, highlighting CDK1 as an additional mPPGL marker. Immunogenomics accompanied by immunohistochemistry identifies a heterogeneous ecosystem at the tumor microenvironment level, linked to the genomic subtype and tumor behavior. Specifically, we define a general immunosuppressive microenvironment in mPPGLs, the exception being PD-L1 expressing\n                    <jats:italic>MAML3<\/jats:italic>\n                    -related tumors. Our study reveals canonical markers for risk of metastasis, and suggests the usefulness of including immune parameters in clinical management for PPGL prognostication and identification of patients who might benefit from immunotherapy.\n                  <\/jats:p>","DOI":"10.1038\/s41467-023-36769-6","type":"journal-article","created":{"date-parts":[[2023,3,2]],"date-time":"2023-03-02T06:29:21Z","timestamp":1677738561000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":93,"title":["Genomic and immune landscape Of metastatic pheochromocytoma and paraganglioma"],"prefix":"10.1038","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6922-9415","authenticated-orcid":false,"given":"Bruna","family":"Calsina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2773-2343","authenticated-orcid":false,"given":"Elena","family":"Pi\u00f1eiro-Y\u00e1\u00f1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1461-4516","authenticated-orcid":false,"given":"\u00c1ngel M.","family":"Mart\u00ednez-Montes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Caleiras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5851-9441","authenticated-orcid":false,"given":"\u00c1ngel","family":"Fern\u00e1ndez-Sanrom\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6280-2987","authenticated-orcid":false,"given":"Mar\u00eda","family":"Monteagudo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3696-4720","authenticated-orcid":false,"given":"Rafael","family":"Torres-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5504-4164","authenticated-orcid":false,"given":"Coral","family":"Fustero-Torre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Pulgar\u00edn-Alfaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Gil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roc\u00edo","family":"Let\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scherezade","family":"Jim\u00e9nez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4540-9446","authenticated-orcid":false,"given":"Santiago","family":"Garc\u00eda-Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Carmen","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Mar\u00eda","family":"Rold\u00e1n-Romero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5054-6007","authenticated-orcid":false,"given":"Javier","family":"Lanillos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Mellid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4279-338X","authenticated-orcid":false,"given":"Alberto","family":"D\u00edaz-Talavera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1ngeles","family":"Rubio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Hernando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6932-333X","authenticated-orcid":false,"given":"Nicole","family":"Bechmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margo","family":"Dona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Calatayud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonsoles","family":"Guadalix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"\u00c1lvarez-Escol\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita M.","family":"Regojo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Aller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Isabel","family":"Del Olmo-Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2844-5998","authenticated-orcid":false,"given":"Adri\u00e0","family":"L\u00f3pez-Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5515-8196","authenticated-orcid":false,"given":"Stephanie M. J.","family":"Fliedner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Rapizzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6170-6398","authenticated-orcid":false,"given":"Martin","family":"Fassnacht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7826-3984","authenticated-orcid":false,"given":"Felix","family":"Beuschlein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Quinkler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3070-6795","authenticated-orcid":false,"given":"Rodrigo A.","family":"Toledo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Mannelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henri J.","family":"Timmers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graeme","family":"Eisenhofer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7221-3636","authenticated-orcid":false,"given":"Sandra","family":"Rodr\u00edguez-Perales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orlando","family":"Dom\u00ednguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3906-467X","authenticated-orcid":false,"given":"Geoffrey","family":"Macintyre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Curr\u00e1s-Freixes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Rodr\u00edguez-Antona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2119-891X","authenticated-orcid":false,"given":"Alberto","family":"Casc\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis J.","family":"Leandro-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4452-4469","authenticated-orcid":false,"given":"Cristina","family":"Montero-Conde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"Roncador","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Fernando","family":"Garc\u00eda-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3541-3767","authenticated-orcid":false,"given":"Karel","family":"Pacak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2373-769X","authenticated-orcid":false,"given":"F\u00e1tima","family":"Al-Shahrour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6256-5902","authenticated-orcid":false,"given":"Mercedes","family":"Robledo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,28]]},"reference":[{"key":"36769_CR1","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.ccell.2017.01.009","volume":"31","author":"PLM Dahia","year":"2017","unstructured":"Dahia, P. L. M. Pheochromocytomas and paragangliomas, genetically diverse and minimalist, all at once! Cancer Cell 31, 159\u2013161 (2017).","journal-title":"Cancer Cell"},{"key":"36769_CR2","doi-asserted-by":"crossref","unstructured":"Hescot, S. et al. Prognosis of malignant pheochromocytoma and paraganglioma (MAPP-PronO study): a European network for the study of adrenal tumors retrospective study. J. Clin. Endocrinol. Metab. 104, 2367\u20132374 (2019).","DOI":"10.1210\/jc.2018-01968"},{"key":"36769_CR3","doi-asserted-by":"publisher","DOI":"10.1210\/endrev\/bnab019","author":"S N\u00f6lting","year":"2021","unstructured":"N\u00f6lting, S. et al. Personalized management of pheochromocytoma and paraganglioma. Endocr. Rev. 43, 199\u2013239 (2022).","journal-title":"Endocr. Rev."},{"key":"36769_CR4","doi-asserted-by":"crossref","unstructured":"Fassnacht, M. et al. Adrenocortical carcinomas and malignant phaeochromocytomas: ESMO\u2013EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up\u2020\u2020Approved by the ESMO Guidelines Committee: June 2020. This publication supersedes the previously published versio. Ann. Oncol. 31, 1476\u20131490 (2020).","DOI":"10.1016\/j.annonc.2020.08.2099"},{"key":"36769_CR5","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.ccell.2017.01.001","volume":"31","author":"L Fishbein","year":"2017","unstructured":"Fishbein, L. et al. Comprehensive molecular characterization of pheochromocytoma and paraganglioma. Cancer Cell 31, 181\u2013193 (2017).","journal-title":"Cancer Cell"},{"key":"36769_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms7044","volume":"6","author":"LJ Castro-Vega","year":"2015","unstructured":"Castro-Vega, L. J. et al. Multi-omics analysis defines core genomic alterations in pheochromocytomas and paragangliomas. Nat. Commun. 6, 6044 (2015).","journal-title":"Nat. Commun"},{"key":"36769_CR7","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1038\/s41568-020-0285-7","volume":"20","author":"D Bruni","year":"2020","unstructured":"Bruni, D., Angell, H. K. & Galon, J. The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy. Nat. Rev. Cancer 20, 662\u2013680 (2020).","journal-title":"Nat. Rev. Cancer"},{"key":"36769_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms7140","volume":"6","author":"L Fishbein","year":"2015","unstructured":"Fishbein, L. et al. Whole-exome sequencing identifies somatic ATRX mutations in pheochromocytomas and paragangliomas. Nat. Commun. 6, 6140 (2015).","journal-title":"Nat. Commun."},{"key":"36769_CR9","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1002\/ijc.29957","volume":"138","author":"A Wilz\u00e9n","year":"2016","unstructured":"Wilz\u00e9n, A. et al. Malignant pheochromocytomas\/paragangliomas harbor mutations in transport and cell adhesion genes. Int. J. Cancer 138, 2201\u20132211 (2016).","journal-title":"Int. J. Cancer"},{"key":"36769_CR10","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/nature12213","volume":"499","author":"MS Lawrence","year":"2013","unstructured":"Lawrence, M. S. et al. Mutational heterogeneity in cancer and the search for new cancer-associated genes. Nature 499, 214\u2013218 (2013).","journal-title":"Nature"},{"key":"36769_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms15180","volume":"8","author":"I Cortes-Ciriano","year":"2017","unstructured":"Cortes-Ciriano, I., Lee, S., Park, W.-Y., Kim, T.-M. & Park, P. J. A molecular portrait of microsatellite instability across multiple cancers. Nat. Commun. 8, 15180 (2017).","journal-title":"Nat. Commun."},{"key":"36769_CR12","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1002\/ijc.22819","volume":"121","author":"HJ Lehtonen","year":"2007","unstructured":"Lehtonen, H. J. et al. Increased HIF1\u03b1 in SDH and FH deficient tumors does not cause microsatellite instability. Int. J. Cancer 121, 1386\u20131389 (2007).","journal-title":"Int. J. Cancer"},{"key":"36769_CR13","doi-asserted-by":"publisher","unstructured":"Bonneville, R. et al. Landscape of microsatellite instability across 39 cancer types. JCO Precis. Oncol. https:\/\/doi.org\/10.1200\/PO.17.00073 (2017).","DOI":"10.1200\/PO.17.00073"},{"key":"36769_CR14","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1038\/nrc3816","volume":"14","author":"SA Roberts","year":"2014","unstructured":"Roberts, S. A. & Gordenin, D. A. Hypermutation in human cancer genomes: footprints and mechanisms. Nat. Rev. Cancer 14, 786\u2013800 (2014).","journal-title":"Nat. Rev. Cancer"},{"key":"36769_CR15","doi-asserted-by":"publisher","first-page":"681","DOI":"10.3390\/cancers11050683","volume":"11","author":"A Casc\u00f3n","year":"2019","unstructured":"Casc\u00f3n, A., Remacha, L., Calsina, B. & Robledo, M. Pheochromocytomas and paragangliomas: bypassing cellular respiration. Cancers (Basel) 11, 681 (2019).","journal-title":"Cancers (Basel)"},{"key":"36769_CR16","doi-asserted-by":"publisher","first-page":"1999 LP","DOI":"10.1073\/pnas.1221068110","volume":"110","author":"C Tomasetti","year":"2013","unstructured":"Tomasetti, C., Vogelstein, B. & Parmigiani, G. Half or more of the somatic mutations in cancers of self-renewing tissues originate prior to tumor initiation. Proc. Natl. Acad. Sci. USA 110, 1999 LP\u20131992004 (2013).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"36769_CR17","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nrc3497","volume":"13","author":"JP de Magalh\u00e3es","year":"2013","unstructured":"de Magalh\u00e3es, J. P. How ageing processes influence cancer. Nat. Rev. Cancer 13, 357\u2013365 (2013).","journal-title":"Nat. Rev. Cancer"},{"key":"36769_CR18","doi-asserted-by":"publisher","first-page":"T41","DOI":"10.1530\/ERC-19-0435","volume":"27","author":"PLM Dahia","year":"2020","unstructured":"Dahia, P. L. M., Clifton-Bligh, R., Gimenez-Roqueplo, A.-P., Robledo, M. & Jimenez, C. HEREDITARY ENDOCRINE TUMOURS: CURRENT STATE-OF-THE-ART AND RESEARCH OPPORTUNITIES: Metastatic pheochromocytomas and paragangliomas: proceedings of the MEN2019 workshop. Endocr. Relat. Cancer 27, T41\u2013T52 (2020).","journal-title":"Endocr. Relat. Cancer"},{"key":"36769_CR19","doi-asserted-by":"publisher","unstructured":"Job, S. et al. Telomerase activation and ATRX mutations are independent risk factors for metastatic pheochromocytoma and paraganglioma. Clin. Cancer Res. https:\/\/doi.org\/10.1158\/1078-0432.CCR-18-0139 (2018).","DOI":"10.1158\/1078-0432.CCR-18-0139"},{"key":"36769_CR20","doi-asserted-by":"publisher","first-page":"3974","DOI":"10.1093\/hmg\/ddr324","volume":"20","author":"N Burnichon","year":"2011","unstructured":"Burnichon, N. et al. Integrative genomic analysis reveals somatic mutations in pheochromocytoma and paraganglioma. Hum. Mol. Genet. 20, 3974\u20133985 (2011).","journal-title":"Hum. Mol. Genet."},{"key":"36769_CR21","doi-asserted-by":"publisher","first-page":"D607","DOI":"10.1093\/nar\/gky1131","volume":"47","author":"D Szklarczyk","year":"2019","unstructured":"Szklarczyk, D. et al. STRING v11: protein\u2013protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 47, D607\u2013D613 (2019).","journal-title":"Nucleic Acids Res."},{"key":"36769_CR22","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1530\/ERC-18-0134","volume":"26","author":"SM O\u2019Toole","year":"2019","unstructured":"O\u2019Toole, S. M. et al. Oncometabolite induced primary cilia loss in pheochromocytoma. Endocr. Relat. Cancer 26, 165\u2013180 (2019).","journal-title":"Endocr. Relat. Cancer"},{"key":"36769_CR23","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1530\/ERC-15-0502","volume":"23","author":"P Crois\u00e9","year":"2016","unstructured":"Crois\u00e9, P. et al. Cdc42 and Rac1 activity is reduced in human pheochromocytoma and correlates with FARP1 and ARHGEF1 expression. Endocr. Relat. Cancer 23, 281\u2013293 (2016).","journal-title":"Endocr. Relat. Cancer"},{"key":"36769_CR24","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1530\/ERC-13-0494","volume":"21","author":"N Kimura","year":"2014","unstructured":"Kimura, N. et al. Pathological grading for predicting metastasis in phaeochromocytoma and paraganglioma. Endocr. Relat. Cancer 21, 405\u2013414 (2014).","journal-title":"Endocr. Relat. Cancer"},{"key":"36769_CR25","doi-asserted-by":"publisher","first-page":"D377","DOI":"10.1093\/nar\/gks1118","volume":"41","author":"H Mi","year":"2013","unstructured":"Mi, H., Muruganujan, A. & Thomas, P. D. PANTHER in 2013: modeling the evolution of gene function, and other gene attributes, in the context of phylogenetic trees. Nucleic Acids Res. 41, D377\u2013D386 (2013).","journal-title":"Nucleic Acids Res."},{"key":"36769_CR26","doi-asserted-by":"publisher","first-page":"3028","DOI":"10.3390\/ijms19103028","volume":"19","author":"C Walker","year":"2018","unstructured":"Walker, C., Mojares, E. & Del R\u00edo Hern\u00e1ndez, A. Role of extracellular matrix in development and cancer progression. Int. J. Mol. Sci. 19, 3028 (2018).","journal-title":"Int. J. Mol. Sci."},{"key":"36769_CR27","doi-asserted-by":"publisher","first-page":"4947","DOI":"10.3390\/ijms20194947","volume":"20","author":"M Paolillo","year":"2019","unstructured":"Paolillo, M. & Schinelli, S. Extracellular matrix alterations in metastatic processes. Int. J. Mol. Sci. 20, 4947 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"36769_CR28","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.5106","author":"C Loriot","year":"2015","unstructured":"Loriot, C. et al. Deciphering the molecular basis of invasiveness in Sdhb-deficient cells. Oncotarget https:\/\/doi.org\/10.18632\/oncotarget.5106 (2015).","journal-title":"Oncotarget"},{"key":"36769_CR29","doi-asserted-by":"publisher","first-page":"4946","DOI":"10.7150\/thno.35458","volume":"9","author":"B Calsina","year":"2019","unstructured":"Calsina, B. et al. Integrative multi-omics analysis identifies a prognostic miRNA signature and a targetable miR-21-3p\/TSC2\/ mTOR axis in metastatic pheochromocytoma\/ paraganglioma. Theranostics 9, 4946\u20134958 (2019).","journal-title":"Theranostics"},{"key":"36769_CR30","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1530\/ERC-12-0183","volume":"20","author":"AA De Cubas","year":"2013","unstructured":"De Cubas, A. A. et al. Integrative analysis of miRNA and mRNA expression profiles in pheochromocytoma and paraganglioma identifies genotype-specific markers and potentially regulated pathways. Endocr. Relat. Cancer 20, 477\u2013493 (2013).","journal-title":"Endocr. Relat. Cancer"},{"key":"36769_CR31","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/nrc.2017.104","volume":"18","author":"J Pelletier","year":"2018","unstructured":"Pelletier, J., Thomas, G. & Volarevi\u0107, S. Ribosome biogenesis in cancer: new players and therapeutic avenues. Nat. Rev. Cancer 18, 51\u201363 (2018).","journal-title":"Nat. Rev. Cancer"},{"key":"36769_CR32","doi-asserted-by":"publisher","first-page":"20467 LP","DOI":"10.1073\/pnas.1218535109","volume":"109","author":"S Bursa\u0107","year":"2012","unstructured":"Bursa\u0107, S. et al. Mutual protection of ribosomal proteins L5 and L11 from degradation is essential for p53 activation upon ribosomal biogenesis stress. Proc. Natl. Acad. Sci. USA 109, 20467 LP\u201320420472 (2012).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"36769_CR33","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.celrep.2013.05.045","volume":"4","author":"G Donati","year":"2013","unstructured":"Donati, G., Peddigari, S., Mercer, C. A. & Thomas, G. 5S ribosomal RNA is an essential component of a nascent ribosomal precursor complex that regulates the Hdm2-p53 checkpoint. Cell Rep. 4, 87\u201398 (2013).","journal-title":"Cell Rep."},{"key":"36769_CR34","doi-asserted-by":"publisher","first-page":"4246","DOI":"10.1128\/MCB.21.13.4246-4255.2001","volume":"21","author":"DG Pestov","year":"2001","unstructured":"Pestov, D. G., Strezoska, Z. & Lau, L. F. Evidence of p53-dependent cross-talk between ribosome biogenesis and the cell cycle: effects of nucleolar protein Bop1 on G(1)\/S transition. Mol. Cell. Biol. 21, 4246\u20134255 (2001).","journal-title":"Mol. Cell. Biol."},{"key":"36769_CR35","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.immuni.2018.03.023","volume":"48","author":"V Thorsson","year":"2018","unstructured":"Thorsson, V. et al. The immune landscape of cancer. Immunity 48, 812\u2013830.e14 (2018).","journal-title":"Immunity"},{"key":"36769_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms3612","volume":"4","author":"K Yoshihara","year":"2013","unstructured":"Yoshihara, K. et al. Inferring tumour purity and stromal and immune cell admixture from expression data. Nat. Commun. 4, 2612 (2013).","journal-title":"Nat. Commun."},{"key":"36769_CR37","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/s41587-019-0114-2","volume":"37","author":"AM Newman","year":"2019","unstructured":"Newman, A. M. et al. Determining cell type abundance and expression from bulk tissues with digital cytometry. Nat. Biotechnol. 37, 773\u2013782 (2019).","journal-title":"Nat. Biotechnol."},{"key":"36769_CR38","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/j.ccell.2021.04.014","volume":"39","author":"A Bagaev","year":"2021","unstructured":"Bagaev, A. et al. Conserved pan-cancer microenvironment subtypes predict response to immunotherapy. Cancer Cell 39, 845\u2013865.e7 (2021).","journal-title":"Cancer Cell"},{"key":"36769_CR39","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1038\/nrd.2018.169","volume":"17","author":"L Cassetta","year":"2018","unstructured":"Cassetta, L. & Pollard, J. W. Targeting macrophages: therapeutic approaches in cancer. Nat. Rev. Drug Discov. 17, 887\u2013904 (2018).","journal-title":"Nat. Rev. Drug Discov."},{"key":"36769_CR40","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.bbcan.2014.01.004","volume":"1845","author":"B Burkholder","year":"2014","unstructured":"Burkholder, B. et al. Tumor-induced perturbations of cytokines and immune cell networks. Biochim. Biophys. Acta - Rev. Cancer 1845, 182\u2013201 (2014).","journal-title":"Biochim. Biophys. Acta - Rev. Cancer"},{"key":"36769_CR41","doi-asserted-by":"crossref","unstructured":"Celada, L. et al. Pseudohypoxia in paraganglioma and pheochromocytoma is associated with an immunosuppressive phenotype. J. Pathol. 259, 103\u2013114 (2022).","DOI":"10.1002\/path.6026"},{"key":"36769_CR42","doi-asserted-by":"publisher","DOI":"10.1007\/s12022-011-9189-0","author":"J Favier","year":"2012","unstructured":"Favier, J. et al. Rationale for anti-angiogenic therapy in pheochromocytoma and paraganglioma. Endocr. Pathol. https:\/\/doi.org\/10.1007\/s12022-011-9189-0 (2012).","journal-title":"Endocr. Pathol."},{"key":"36769_CR43","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1210\/er.2017-00062","volume":"38","author":"J Crona","year":"2017","unstructured":"Crona, J., Ta\u00efeb, D. & Pacak, K. New perspectives on pheochromocytoma and paraganglioma: toward a molecular classification. Endocr. Rev 38, 489\u2013515 (2017).","journal-title":"Endocr. Rev"},{"key":"36769_CR44","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1093\/annonc\/mdx755","volume":"29","author":"J Tang","year":"2018","unstructured":"Tang, J., Shalabi, A. & Hubbard-Lucey, V. M. Comprehensive analysis of the clinical immuno-oncology landscape. Ann. Oncol. 29, 84\u201391 (2018).","journal-title":"Ann. Oncol."},{"key":"36769_CR45","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1046\/j.1365-2141.2001.02920.x","volume":"114","author":"EP Das-Gupta","year":"2001","unstructured":"Das-Gupta, E. P., Seedhouse, C. H. & Russell, N. H. Microsatellite instability occurs in defined subsets of patients with acute myeloblastic leukaemia. Br. J. Haematol. 114, 307\u2013312 (2001).","journal-title":"Br. J. Haematol."},{"key":"36769_CR46","doi-asserted-by":"publisher","first-page":"e25419","DOI":"10.4161\/onci.25419","volume":"2","author":"C Maletzki","year":"2013","unstructured":"Maletzki, C., Stier, S. & Linnebacher, M. Microsatellite instability in hematological malignancies. Oncoimmunology 2, e25419 (2013).","journal-title":"Oncoimmunology"},{"key":"36769_CR47","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1677\/ERC-09-0310","volume":"17","author":"J Sandgren","year":"2010","unstructured":"Sandgren, J. et al. Recurrent genomic alterations in benign and malignant pheochromocytomas and paragangliomas revealed by whole-genome array comparative genomic hybridization analysis. Endocr. Relat. Cancer 17, 561\u2013579 (2010).","journal-title":"Endocr. Relat. Cancer"},{"key":"36769_CR48","doi-asserted-by":"publisher","first-page":"e37294","DOI":"10.7554\/eLife.37294","volume":"7","author":"H Hieronymus","year":"2018","unstructured":"Hieronymus, H. et al. Tumor copy number alteration burden is a pan-cancer prognostic factor associated with recurrence and death. Elife 7, e37294 (2018).","journal-title":"Elife"},{"key":"36769_CR49","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1126\/science.aao0535","volume":"357","author":"C Kunitoshi","year":"2017","unstructured":"Kunitoshi, C. et al. Mutations in the promoter of the telomerase gene TERT contribute to tumorigenesis by a two-step mechanism. Science 357, 1416\u20131420 (2017).","journal-title":"Science"},{"key":"36769_CR50","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1038\/s41588-018-0179-8","volume":"50","author":"G Macintyre","year":"2018","unstructured":"Macintyre, G. et al. Copy number signatures and mutational processes in ovarian carcinoma. Nat. Genet. 50, 1262\u20131270 (2018).","journal-title":"Nat. Genet."},{"key":"36769_CR51","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1530\/ERC-14-0016","volume":"21","author":"T Liu","year":"2014","unstructured":"Liu, T. et al. The activating TERT promoter mutation C228T is recurrent in subsets of adrenal tumors. Endocr. Relat. Cancer 21, 427\u2013434 (2014).","journal-title":"Endocr. Relat. Cancer"},{"key":"36769_CR52","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1530\/ERC-13-0429","volume":"21","author":"TG Papathomas","year":"2014","unstructured":"Papathomas, T. G. et al. Telomerase reverse transcriptase promoter mutations in tumors originating from the adrenal gland and extra-adrenal paraganglia. Endocr. Relat. Cancer 21, 653\u2013661 (2014).","journal-title":"Endocr. Relat. Cancer"},{"key":"36769_CR53","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s00439-015-1631-9","volume":"135","author":"J Meienberg","year":"2016","unstructured":"Meienberg, J., Bruggmann, R., Oexle, K. & Matyas, G. Clinical sequencing: is WGS the better WES? Hum. Genet. 135, 359\u2013362 (2016).","journal-title":"Hum. Genet."},{"key":"36769_CR54","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1038\/nature06046","volume":"448","author":"D Santamar\u00eda","year":"2007","unstructured":"Santamar\u00eda, D. et al. Cdk1 is sufficient to drive the mammalian cell cycle. Nature 448, 811\u2013815 (2007).","journal-title":"Nature"},{"key":"36769_CR55","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-34011-3","volume":"13","author":"M Zethoven","year":"2022","unstructured":"Zethoven, M. et al. Single-nuclei and bulk-tissue gene-expression analysis of pheochromocytoma and paraganglioma links disease subtypes with tumor microenvironment. Nat. Commun. 13, 6262 (2022).","journal-title":"Nat. Commun."},{"key":"36769_CR56","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/nrc.2016.138","volume":"17","author":"T Otto","year":"2017","unstructured":"Otto, T. & Sicinski, P. Cell cycle proteins as promising targets in cancer therapy. Nat. Rev. Cancer 17, 93\u2013115 (2017).","journal-title":"Nat. Rev. Cancer"},{"key":"36769_CR57","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.ando.2019.04.003","volume":"80","author":"J Goncalves","year":"2019","unstructured":"Goncalves, J., Lussey-Lepoutre, C., Favier, J., Gimenez-Roqueplo, A.-P. & Castro-Vega, L. J. Emerging molecular markers of metastatic pheochromocytomas and paragangliomas. Ann. Endocrinol. 80, 159\u2013162 (2019).","journal-title":"Ann. Endocrinol."},{"key":"36769_CR58","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1038\/nrclinonc.2017.101","volume":"14","author":"WH Fridman","year":"2017","unstructured":"Fridman, W. H., Zitvogel, L., Saut\u00e8s\u2013Fridman, C. & Kroemer, G. The immune contexture in cancer prognosis and treatment. Nat. Rev. Clin. Oncol. 14, 717\u2013734 (2017).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"36769_CR59","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1007\/s12022-019-9575-6","volume":"30","author":"NA Farhat","year":"2019","unstructured":"Farhat, N. A. et al. A previously unrecognized monocytic component of pheochromocytoma and paraganglioma. Endocr. Pathol. 30, 90\u201395 (2019).","journal-title":"Endocr. Pathol."},{"key":"36769_CR60","doi-asserted-by":"publisher","first-page":"851","DOI":"10.3389\/fendo.2020.587779","volume":"11","author":"X Gao","year":"2020","unstructured":"Gao, X. et al. Histopathological analysis of tumor microenvironment and angiogenesis in pheochromocytoma. Front. Endocrinol. 11, 851 (2020).","journal-title":"Front. Endocrinol."},{"key":"36769_CR61","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41416-018-0327-z","volume":"120","author":"NA Giraldo","year":"2019","unstructured":"Giraldo, N. A. et al. The clinical role of the TME in solid cancer. Br. J. Cancer 120, 45\u201353 (2019).","journal-title":"Br. J. Cancer"},{"key":"36769_CR62","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/nri1806","volume":"6","author":"W Zou","year":"2006","unstructured":"Zou, W. Regulatory T cells, tumour immunity and immunotherapy. Nat. Rev. Immunol. 6, 295\u2013307 (2006).","journal-title":"Nat. Rev. Immunol."},{"key":"36769_CR63","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s11481-012-9395-7","volume":"8","author":"C Sarkar","year":"2013","unstructured":"Sarkar, C., Chakroborty, D. & Basu, S. Neurotransmitters as regulators of tumor angiogenesis and immunity: the role of catecholamines. J. Neuroimmune Pharmacol. 8, 7\u201314 (2013).","journal-title":"J. Neuroimmune Pharmacol."},{"key":"36769_CR64","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.cmet.2016.08.011","volume":"24","author":"A Brand","year":"2016","unstructured":"Brand, A. et al. LDHA-associated lactic acid production blunts tumor immunosurveillance by T and NK cells. Cell Metab. 24, 657\u2013671 (2016).","journal-title":"Cell Metab."},{"key":"36769_CR65","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.cmet.2019.06.001","volume":"30","author":"I Vitale","year":"2019","unstructured":"Vitale, I., Manic, G., Coussens, L. M., Kroemer, G. & Galluzzi, L. Macrophages and metabolism in the tumor microenvironment. Cell Metab. 30, 36\u201350 (2019).","journal-title":"Cell Metab."},{"key":"36769_CR66","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/nrc3245","volume":"12","author":"WH Fridman","year":"2012","unstructured":"Fridman, W. H., Pag\u00e8s, F., Saut\u00e8s-Fridman, C. & Galon, J. The immune contexture in human tumours: impact on clinical outcome. Nat. Rev. Cancer 12, 298\u2013306 (2012).","journal-title":"Nat. Rev. Cancer"},{"key":"36769_CR67","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-021-00552-7","author":"L Kraehenbuehl","year":"2021","unstructured":"Kraehenbuehl, L., Weng, C.-H., Eghbali, S., Wolchok, J. D. & Merghoub, T. Enhancing immunotherapy in cancer by targeting emerging immunomodulatory pathways. Nat. Rev. Clin. Oncol. https:\/\/doi.org\/10.1038\/s41571-021-00552-7 (2021).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"36769_CR68","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/s41577-020-0306-5","volume":"20","author":"AD Waldman","year":"2020","unstructured":"Waldman, A. D., Fritz, J. M. & Lenardo, M. J. A guide to cancer immunotherapy: from T cell basic science to clinical practice. Nat. Rev. Immunol. 20, 651\u2013668 (2020).","journal-title":"Nat. Rev. Immunol."},{"key":"36769_CR69","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1038\/nature13954","volume":"515","author":"PC Tumeh","year":"2014","unstructured":"Tumeh, P. C. et al. PD-1 blockade induces responses by inhibiting adaptive immune resistance. Nature 515, 568\u2013571 (2014).","journal-title":"Nature"},{"key":"36769_CR70","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cancers12082307","volume":"12","author":"C Jimenez","year":"2020","unstructured":"Jimenez, C. et al. Phase II clinical trial of pembrolizumab in patients with progressive metastatic pheochromocytomas and paragangliomas. Cancers 12, 1\u201315 (2020).","journal-title":"Cancers"},{"key":"36769_CR71","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1038\/s41591-019-0434-2","volume":"25","author":"W Yang","year":"2019","unstructured":"Yang, W. et al. Immunogenic neoantigens derived from gene fusions stimulate T cell responses. Nat. Med. 25, 767\u2013775 (2019).","journal-title":"Nat. Med."},{"key":"36769_CR72","doi-asserted-by":"publisher","first-page":"3074","DOI":"10.1158\/1078-0432.CCR-18-1942","volume":"25","author":"JJ Luke","year":"2019","unstructured":"Luke, J. J., Bao, R., Sweis, R. F., Spranger, S. & Gajewski, T. F. WNT\/\u03b2-catenin pathway activation correlates with immune exclusion across human cancers. Clin. Cancer Res. 25, 3074\u20133083 (2019).","journal-title":"Clin. Cancer Res."},{"key":"36769_CR73","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1126\/science.aac9935","volume":"352","author":"CS C","year":"2016","unstructured":"C, C. S. et al. MYC regulates the antitumor immune response through CD47 and PD-L1. Science. 352, 227\u2013231 (2016).","journal-title":"Science."},{"key":"36769_CR74","doi-asserted-by":"publisher","first-page":"e20191115","DOI":"10.1084\/jem.20191115","volume":"217","author":"L Du","year":"2020","unstructured":"Du, L. et al. \u03b2-Catenin induces transcriptional expression of PD-L1 to promote glioblastoma immune evasion. J. Exp. Med. 217, e20191115 (2020).","journal-title":"J. Exp. Med."},{"key":"36769_CR75","doi-asserted-by":"publisher","first-page":"3435","DOI":"10.1172\/JCI128562","volume":"129","author":"DN Khalil","year":"2019","unstructured":"Khalil, D. N. et al. In situ vaccination with defined factors overcomes T cell exhaustion in distant tumors. J. Clin. Invest. 129, 3435\u20133447 (2019).","journal-title":"J. Clin. Invest."},{"key":"36769_CR76","doi-asserted-by":"publisher","first-page":"654","DOI":"10.3390\/cancers11050654","volume":"11","author":"V Caisova","year":"2019","unstructured":"Caisova, V. et al. The significant reduction or complete eradication of subcutaneous and metastatic lesions in a pheochromocytoma mouse model after immunotherapy using Mannan-BAM, TLR ligands, and anti-CD40. Cancers 11, 654 (2019).","journal-title":"Cancers"},{"key":"36769_CR77","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/s41591-018-0014-x","volume":"24","author":"M Binnewies","year":"2018","unstructured":"Binnewies, M. et al. Understanding the tumor immune microenvironment (TIME) for effective therapy. Nat. Med. 24, 541\u2013550 (2018).","journal-title":"Nat. Med."},{"key":"36769_CR78","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1007\/s12022-022-09704-6","volume":"33","author":"O Mete","year":"2022","unstructured":"Mete, O. et al. Overview of the 2022 WHO Classification of paragangliomas and pheochromocytomas. Endocr. Pathol. 33, 90\u2013114 (2022).","journal-title":"Endocr. Pathol."},{"key":"36769_CR79","doi-asserted-by":"publisher","first-page":"4758","DOI":"10.3390\/cancers13194758","volume":"13","author":"M Monteagudo","year":"2021","unstructured":"Monteagudo, M. et al. Analysis of telomere maintenance related genes reveals NOP10 as a new metastatic-risk marker in pheochromocytoma\/paraganglioma. Cancers 13, 4758 (2021).","journal-title":"Cancers"},{"key":"36769_CR80","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","volume":"25","author":"H Li","year":"2009","unstructured":"Li, H. & Durbin, R. Fast and accurate short read alignment with Burrows\u2013Wheeler transform. Bioinformatics 25, 1754\u20131760 (2009).","journal-title":"Bioinformatics"},{"key":"36769_CR81","unstructured":"Van der Auwera, G. A. & O\u2019Connor, B. D. Genomics in the Cloud: Using Docker, GATK, and WDL in Terra (O\u2019Reilly Media, Inc., 2020)."},{"key":"36769_CR82","doi-asserted-by":"publisher","unstructured":"Poplin, R. et al. Scaling accurate genetic variant discovery to tens of thousands of samples. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/201178 (2018).","DOI":"10.1101\/201178"},{"key":"36769_CR83","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/nbt.2514","volume":"31","author":"K Cibulskis","year":"2013","unstructured":"Cibulskis, K. et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat. Biotechnol. 31, 213\u2013219 (2013).","journal-title":"Nat. Biotechnol."},{"key":"36769_CR84","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-016-0974-4","volume":"17","author":"W McLaren","year":"2016","unstructured":"McLaren, W. et al. The ensembl variant effect predictor. Genome Biol. 17, 122 (2016).","journal-title":"Genome Biol."},{"key":"36769_CR85","doi-asserted-by":"publisher","first-page":"e131","DOI":"10.1093\/nar\/gkw520","volume":"44","author":"R Shen","year":"2016","unstructured":"Shen, R. & Seshan, V. E. FACETS: allele-specific copy number and clonal heterogeneity analysis tool for high-throughput DNA sequencing. Nucleic Acids Res. 44, e131\u2013e131 (2016).","journal-title":"Nucleic Acids Res."},{"key":"36769_CR86","doi-asserted-by":"publisher","first-page":"7452","DOI":"10.18632\/oncotarget.13918","volume":"8","author":"EA Kautto","year":"2017","unstructured":"Kautto, E. A. et al. Performance evaluation for rapid detection of pan-cancer microsatellite instability with MANTIS. Oncotarget 8, 7452\u20137463 (2017).","journal-title":"Oncotarget"},{"key":"36769_CR87","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/nbt.1754","volume":"29","author":"JT Robinson","year":"2011","unstructured":"Robinson, J. T. et al. Integrative genomics viewer. Nat. Biotechnol. 29, 24\u201326 (2011).","journal-title":"Nat. Biotechnol."},{"key":"36769_CR88","doi-asserted-by":"publisher","first-page":"3439","DOI":"10.1093\/bioinformatics\/bti525","volume":"21","author":"S Durinck","year":"2005","unstructured":"Durinck, S. et al. BioMart and Bioconductor: a powerful link between biological databases and microarray data analysis. Bioinformatics 21, 3439\u20133440 (2005).","journal-title":"Bioinformatics"},{"key":"36769_CR89","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/S1470-2045(13)70110-4","volume":"14","author":"P Castelo-Branco","year":"2013","unstructured":"Castelo-Branco, P. et al. Methylation of the TERT promoter and risk stratification of childhood brain tumours: an integrative genomic and molecular study. Lancet Oncol. 14, 534\u2013542 (2013).","journal-title":"Lancet Oncol"},{"key":"36769_CR90","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2011-12-4-r41","volume":"12","author":"CH Mermel","year":"2011","unstructured":"Mermel, C. H. et al. GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers. Genome Biol. 12, R41 (2011).","journal-title":"Genome Biol."},{"key":"36769_CR91","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/ng.3781","volume":"49","author":"FP Barthel","year":"2017","unstructured":"Barthel, F. P. et al. Systematic analysis of telomere length and somatic alterations in 31 cancer types. Nat. Genet. 49, 349\u2013357 (2017).","journal-title":"Nat. Genet."},{"key":"36769_CR92","doi-asserted-by":"publisher","first-page":"583","DOI":"10.2174\/1574893612666170810153850","volume":"13","author":"O Gra\u00f1a","year":"2017","unstructured":"Gra\u00f1a, O., Rubio-Camarillo, M., Fdez-Riverola, F., Pisano, D. G. & Glez-Pe\u00f1a, D. Nextpresso: next generation sequencing expression analysis pipeline. Curr. Bioinform. 13, 583\u2013591 (2017).","journal-title":"Curr. Bioinform."},{"key":"36769_CR93","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2013-14-4-r36","volume":"14","author":"D Kim","year":"2013","unstructured":"Kim, D. et al. TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions. Genome Biol. 14, R36 (2013).","journal-title":"Genome Biol."},{"key":"36769_CR94","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15\u201321 (2013).","journal-title":"Bioinformatics"},{"key":"36769_CR95","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1093\/biostatistics\/kxj037","volume":"8","author":"WE Johnson","year":"2007","unstructured":"Johnson, W. E., Li, C. & Rabinovic, A. Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics 8, 118\u2013127 (2007).","journal-title":"Biostatistics"},{"key":"36769_CR96","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1093\/bioinformatics\/bts034","volume":"28","author":"JT Leek","year":"2012","unstructured":"Leek, J. T., Johnson, W. E., Parker, H. S., Jaffe, A. E. & Storey, J. D. The sva package for removing batch effects and other unwanted variation in high-throughput experiments. Bioinformatics 28, 882\u2013883 (2012).","journal-title":"Bioinformatics"},{"key":"36769_CR97","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."},{"key":"36769_CR98","doi-asserted-by":"publisher","first-page":"513 LP","DOI":"10.1136\/jmedgenet-2018-105714","volume":"56","author":"L Ben Aim","year":"2019","unstructured":"Ben Aim, L. et al. Targeted next-generation sequencing detects rare genetic events in pheochromocytoma and paraganglioma. J. Med. Genet. 56, 513 LP\u2013513520 (2019).","journal-title":"J. Med. Genet."},{"key":"36769_CR99","doi-asserted-by":"publisher","first-page":"15545 LP","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA 102, 15545 LP\u201315515550 (2005).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"36769_CR100","doi-asserted-by":"publisher","first-page":"1","DOI":"10.12688\/f1000research.25141.1","volume":"9","author":"JA Eddy","year":"2020","unstructured":"Eddy, J. A. et al. CRI iAtlas: an interactive portal for immuno-oncology research. F1000Research 9, 1\u201316 (2020).","journal-title":"F1000Research"},{"key":"36769_CR101","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S H\u00e4nzelmann","year":"2013","unstructured":"H\u00e4nzelmann, S., Castelo, R. & Guinney, J. GSVA: gene set variation analysis for microarray and RNA-Seq data. BMC Bioinform. 14, 7 (2013).","journal-title":"BMC Bioinform."},{"key":"36769_CR102","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1158\/2326-6066.CIR-19-0401","volume":"8","author":"J Hundal","year":"2020","unstructured":"Hundal, J. et al. pVACtools: a computational toolkit to identify and visualize cancer neoantigens. Cancer Immunol. Res. 8, 409\u2013420 (2020).","journal-title":"Cancer Immunol. Res."},{"key":"36769_CR103","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1038\/nbt.3344","volume":"33","author":"SA Shukla","year":"2015","unstructured":"Shukla, S. A. et al. Comprehensive analysis of cancer-associated somatic mutations in class I HLA genes. Nat. Biotechnol. 33, 1152\u20131158 (2015).","journal-title":"Nat. Biotechnol."},{"key":"36769_CR104","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-17204-5","volume":"7","author":"P Bankhead","year":"2017","unstructured":"Bankhead, P. et al. QuPath: open source software for digital pathology image analysis. Sci. Rep. 7, 16878 (2017).","journal-title":"Sci. Rep."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-36769-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-36769-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-36769-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,2]],"date-time":"2023-03-02T06:29:26Z","timestamp":1677738566000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-36769-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,28]]},"references-count":104,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["36769"],"URL":"https:\/\/doi.org\/10.1038\/s41467-023-36769-6","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,28]]},"assertion":[{"value":"5 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"G.M., is a founder, director and shareholder of Tailor Bio Ltd, a genomics company using copy number signatures for precision medicine. The rest of the authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1122"}}